Compare CMRC & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CMRC | USBC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | |
| Employees | N/A | 6 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.0M | 333.2M |
| IPO Year | 2020 | N/A |
| Metric | CMRC | USBC |
|---|---|---|
| Price | $4.33 | $0.72 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 666.3K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $339,860,000.00 | N/A |
| Revenue This Year | $5.15 | N/A |
| Revenue Next Year | $4.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.97 | N/A |
| 52 Week Low | $4.14 | N/A |
| 52 Week High | $7.69 | N/A |
| Indicator | CMRC | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 36.97 | 41.04 |
| Support Level | $4.46 | $0.75 |
| Resistance Level | $4.61 | $0.91 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 2.88 | 11.22 |
Commerce.com Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of its revenue is generated from Americas-U.S.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.